Improving muscle mass and function in cachexia: Non-drug approaches

Current Opinion in Supportive and Palliative Care

Volumn 5, Issue 4, 2011, Pages 361-364

  Maddocks, Matthew ^a   Murton, Andrew J ^a   Wilcock, Andrew ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Cachexia; Muscle mass; Therapeutic exercise

Indexed keywords

CACHEXIA; HUMAN; INFLAMMATION; INSULIN RESISTANCE; KINESIOTHERAPY; METABOLISM; METHODOLOGY; MUSCLE CONTRACTION; NEOPLASM; PHYSIOLOGY; REVIEW; SKELETAL MUSCLE;

CACHEXIA; EXERCISE THERAPY; HUMANS; INFLAMMATION; INSULIN RESISTANCE; MUSCLE CONTRACTION; MUSCLE, SKELETAL; NEOPLASMS;

EID: 84856867281     PISSN: 17514258     EISSN: 17514266     Source Type: Journal    
DOI: 10.1097/SPC.0b013e32834bdde3     Document Type: Review

References (46)

1. Muscaritoli M, Anker SD, Argiles J, et al. Consensus definition of sarcopenia, cachexia and precachexia: Joint document elaborated by Specialist Interest Groups (SIG) 'cachexia-anorexia in chronic wasting diseases' and 'nutrition in genetics'. Clin Nutr 2010; 29:154-159.
2. Dodson S, Baracos VE, Jatoi A, et al. Muscle wasting in cancer cachexia: Clinical implications, diagnosis, and emerging treatment strategies. Ann Rev Med 2011; 62:265-279. A contemporary account of assessment techniques and promising treatment options for the management of muscle wasting in cancer cachexia.
3. Blum D, Omlin A, Baracos VE, et al. Cancer cachexia: A systematic literature review of items and domains associated with involuntary weight loss in cancer. Crit Rev Oncol Hematol 2011 Jan 7. [Epub ahead of print]
4. Fearon K, Strasser F, Anker SD, et al. Definition and classification of cancer cachexia: An international consensus. Lancet Oncol 2011; 12:489-495. This paper outlines an internationally agreed framework on the definition, classification and assessment of cancer cachexia derived from a formal consensus process. Of particular use to those involved in clinical trials in this setting.
5. Fearon KCH. Cancer cachexia: Developing multimodal therapy for a multidimensional problem. Eur J Cancer 2008; 44:1124-1132.
6. Lenk K, Schuler G, Adams V. Skeletal muscle wasting in cachexia and sarcopenia: Molecular pathophysiology and impact of exercise training. J Cachex Sarcopenia Muscle 2010; 1:9-21.
7. Little JP, Phillips SM. Resistance exercise and nutrition to counteract muscle wasting. Appl Physiol Nutr Metab 2009; 34:817-828.
8. Glover EI, Phillips SM. Resistance exercise and appropriate nutrition to counteract muscle wasting and promote muscle hypertrophy. Curr Opin Clin Nutr Metab Care 2010; 13:630-634.
9. Morley JE, Argiles JM, Evans WJ, et al. Nutritional recommendations for the management of sarcopenia. J Am Med Dir Assoc 2010; 11:391-396.
10. Murton AJ, Greenhaff PL. Physiological control of muscle mass in humans during resistance exercise, disuse and rehabilitation. Curr Opin Clin Nutr Metab Care 2010; 13:249-254.
11. Murton AJ, Constantin D, Greenhaff PL. The involvement of the ubiquitin proteasome system in human skeletal muscle remodelling and atrophy. Biochim Biophys Acta 2008; 1782:730-743.
12. Glover EL, Phillips SM, Oates BR, et al. Immobilization induces anabolic resistance in human myofibrillar protein synthesis with low and high dose amino acid infusion. J Physiol 2008; 586:6049-6061.
13. Cuthbertson D, Smith K, Babraj J, et al. Anabolic signalling degicits underlie amino acid resistance of wasting, aging muscle. FASEB J 2005; 19:422-424. (Pubitemid 40316537)
14. James WPT. Protein synthesis and breakdown and amino acid catabolism in protein-calorie malnutrition. Proc Nutr Soc 1972; 31:225-231.
15. Adams V, Mangner N, Gasch A, et al. Induction of MuRF1 is essential for TNF-a induced loss of muscle function in mice. J Mol Biol 2008; 384:48-59.
16. Sish BJ, Engelbrecht AM. Tumor necrosis factor alpha (TNF-a) inactivates the PI3-kinase/PKB pathway and induces atrophy and apoptosis in L6 myotubes. Cytokine 2011; 54:173-184.
17. Biolo G, Maggi SP, Williams BD, et al. Increased rates of muscle protein turnover and amino acid transport after resistance exercise in humans. Am J Physiol Endocrinol Metab 1995; 268:E514-E520.
18. Wolsk E, Mygind H, Grøndahl TS, et al. IL-6 selectively stimulates fat metabolism in human skeletal muscle. Am J Physiol Endocrinol Metab 2010; 299:E832-E840. This paper describes a study exploring the effects of IL-6 on fat and glucose metabolism in healthy volunteers.
19. Starkie R, Ostrowski SR, Jauffred S, et al. Exercise and IL-6 infusion inhibit endotoxin-induced TNFa production in humans. FASEB J 2003; 17:884-886.
20. Wang X, Hu Z, J Hu, et al. Insulin resistance accelerates muscle protein degradation: Activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling. Endocrinology 2006; 147:4160-4168. (Pubitemid 44268367)
21. Spence RR, Heesch KC, Brown WJ. Exercise and cancer rehabilitation: A systematic review. Cancer Treatment Rev 2010; 36:185-194.
22. Fillipas S, Cherry CL, Cicuttini F, et al. The effects of exercise training on metabolic and morphological outcomes for people living with HIV: A systematic review of randomised controlled trials. HIV Clin Trials 2010; 11:270-282.
23. Cooney JK, Law R-J, Matschke V, et al. Benefits of exercise in rheumatoid arthritis. J Aging Res 2011; 2011:681640.
24. Renk H, Krakowski-Roosen H, Weber MA, et al. Progressive resistance training for restitution of muscle mass and strength in human cancer cachexia. 3rd Cachexia Conference 8th-10th December 2005; 3:49.
25. Vogiatzis I, Simoes DCM, Stratakos G, et al. Effect of pulmonary rehabilitation on muscle remodelling in cachectic patients with COPD. Eur Respir J 2010; 36:301-310. A study that demonstrates that peripheral muscle retains the capacity to respond to exercise training, even in the presence cachexia and that improvements in muscle mass and function can benefit overall exercise capacity.
26. Coats AJS. Origin of symptoms in patients with cachexia with special reference to weakness and shortness of breath. Int J Cardiol 2002; 85:133-139.
27. Biolo G, Ciocchi B, Stulle M, et al. Metabolic consequences of physical inactivity. J Renal Nutr 2005; 15:49-53. (Pubitemid 40093682)
28. Baracos VE. A deadly combination of anorexia and hypermetabolism. Curr Opin Clin Nutr Metab Care 2001; 4:175-177.
29. Seruga B, Zhang H, Bernstein LJ, et al. Cytokines and their relationship to the symptoms and outcome of cancer. Nature Rev Cancer 2008; 8:887-899.
30. Kumar NB, Kazi A, Smith T, et al. Cancer cachexia: Traditional therapies and novel molecular mechanism-based approaches to treatment. Curr Treat Opt Oncol 2010; 11:107-117.
31. Fischer MJ, Scharloo M, Abbink JJ, et al. Drop-out and attendance in pulmonary rehabilitation: The role of clinical and psychosocial variables. Respir Med 2009; 103:1564-1571.
32. Maddocks M, Mockett S, Wilcock A. Is exercise an acceptable and practical therapy for people with or cured of cancer? A systematic review. Cancer Treatment Rev 2009; 35:383-390.
33. Temel JS, Greer JA, Goldberg S, et al. A structured exercise program for patients with advanced nonsmall cell lung cancer. J Thorac Oncol 2009; 4:595-601.
34. Glare P, Jongs W, Zafiropoulos B. Establishing a cancer nutrition rehabilitation program (CNRP) for ambulatory patients attending an Australian cancer center. Support Care Cancer 2011; 19:445-454.
35. Burd NA, West DW, Staples AW, et al. Low-load high volume resistance exercise stimulates muscle protein synthesis more than high-load low volume resistance exercise in young men. PLoS One 2010; 5:e12033. A healthy volunteer study that found there was benefit from exercise even at modest workloads.
36. Maddocks M, Armstrong S, Wilcock A. Exercise as a supportive therapy in incurable cancer: Exploring patient preferences. Psychooncology 2011; 20:173-178.
37. Lowe SS, Watanabe SM, Baracos VE, et al. Physical activity interests and preference in palliative cancer patients. Support Care Cancer 2010; 18:1469-1475.
38. Dehail P, Duclos C, Barat M. Electrical stimulation and muscle strengthening. Ann Readapt Med Phys 2008; 51:441-451.
39. Roig M, Reid WD. Electrical stimulation and peripheral muscle function in COPD: A systematic review. Respir Med 2009; 103:485-495.
40. Sillen MJH, Speksnijer CM, Eterman R-MA, et al. Effects of neuromuscular electrical stimulation of muscles of ambulation in patients with chronic heart failure or COPD: A systematic review of the English-language literature. CHEST 2009; 136:44-61.
41. Piva SR, Goodnite EA, Azuma K, et al. Neuromuscular electrical stimulation and volitional exercise for individuals with rheumatoid arthritis: A multiplepatient case report. Phys Ther 2007; 87:1064-1077. (Pubitemid 47204512)
42. Maddocks M, Lewis M, Chauhan A, et al. Randomized controlled pilot study of neuromuscular electrical stimulation of the quadriceps in patients with nonsmall cell lung cancer. J Pain Symptom Manage 2009; 38:950-956.
43. Dal Corso S, Nápolis L, Malaguti C, et al. Skeletal muscle structure and function in response to electrical stimulation in moderately impaired COPD patients. Resp Med 2007; 101:1236-1243. (Pubitemid 46667669)
44. Nuhr MJ, Pette D, Berger R, et al. Beneficial effects of chronic low-frequency stimulation of thigh muscles in patients with advanced chronic heart failure. Eur Heart J 2004; 25:136-143. (Pubitemid 38112152)
45. Vivodtzev I, Pepin J-L, Vottero G, et al. Improvement in quadriceps strength and dyspnea in daily tasks after 1 month of electrical stimulation in severely deconditioned and malnourished COPD. CHEST 2006; 129:1540-1548. (Pubitemid 43894983)
46. Maffiuletti NA. Physiological and methodological considerations for the use of neuromuscular electrical stimulation. Eur J Apply Physiol 2010; 110:223-234. A review outlining the theoretical and practical aspects of the use of neuromuscular electrical stimulation.